Iovance Biotherapeutics (IOVA) Receivables (2023 - 2026)
Iovance Biotherapeutics (IOVA) posted Receivables of $102.12 million for Q2 2026, up 70.4% from $59.94 million a year earlier and up 24.9% from the prior quarter.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) Receivables (2023 - 2026) Analysis & Trends
At the end of FY2025, Iovance Biotherapeutics' Receivables came in at $82.45 million, up 18.9% from FY2024.
- In prior years, Iovance Biotherapeutics' Receivables was $69.34 million in FY2024 and $151,000 in FY2023.
- The Q2 2026 figure stands as the highest quarterly Receivables in data going back to Q2 2023.
- On a year-over-year basis, Receivables has increased in each of the last five quarters, with growth averaging 42.8% over the last five quarters.
- According to Business Quant data, Receivables for the three prior quarters was $81.76 million (Q1 2026), $82.45 million (Q4 2025) and $66.76 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 16.16 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Iovance Biotherapeutics | 3.74 Bn | 2.45 Bn | 73.44 Mn | 106.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 106.99 Mn |
| Jun 30, 2026 | 102.12 Mn |
| Mar 31, 2026 | 81.76 Mn |
| Dec 31, 2025 | 82.45 Mn |
| Sep 30, 2025 | 66.76 Mn |
| Jun 30, 2025 | 59.94 Mn |
| Mar 31, 2025 | 70.94 Mn |
| Dec 31, 2024 | 69.34 Mn |
| Sep 30, 2024 | 55.77 Mn |
| Jun 30, 2024 | 31.60 Mn |
| Mar 31, 2024 | 234,000.00 |
| Dec 31, 2023 | 151,000.00 |
| Jun 30, 2023 | 33,000.00 |
API Access
Iovance Biotherapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=IOVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();